Treatment of<unk>  depends on the severity and location of the disease. The following are treatment options for this condition: *Oral potassium iodide :Potassium iodide is an anti-fungal drug that is widely used as a treatment for cutaneous<unk> . Despite its wide use, there is no high-quality evidence for or against this practice. Further studies are needed to assess the efficacy and safety of oral potassium iodide in the treatment of<unk> . *Itraconazole (Sporanox) and fluconazole :These are antifungal drugs. Itraconazole is currently the drug of choice and is significantly more effective than fluconazole. Fluconazole should be reserved for patients who cannot tolerate itraconazole. *Amphotericin B :This antifungal medication is delivered intravenously. Many patients, however, cannot tolerate Amphotericin B due to its potential side effects of fever, nausea, and vomiting. :Lipid formulations of amphotericin B are usually recommended instead of amphotericin B deoxycholate because of a better adverse-effect profile. Amphotericin B can be used for severe infection during pregnancy. For children with disseminated or severe disease, amphotericin B deoxycholate can be used initially, followed by itraconazole. :In case of<unk>  meningitis, the patient may be given a combination of Amphotericin B and 5-fluorocytosine/Flucytosine. *Terbinafine :500mg and 1000mg daily dosages of terbinafine for twelve to 24 weeks has been used to treat cutaneous<unk> . *Newer triazoles :Several studies have shown that posaconazole has in vitro activity similar to that of amphotericin B and itraconazole; therefore, it shows promise as an alternative therapy. However, voriconazole susceptibility varies. Because the correlation between in vitro data and clinical response has not been demonstrated, there is insufficient evidence to recommend either posaconazole or voriconazole for treatment of<unk>  at this time. *Surgery :In cases of bone infection and cavitary nodules in the lungs, surgery may be necessary. *Heat therapy :Heat creates higher tissue temperatures, which may inhibit fungus growth while the immune system counteracts the infection. The "pocket warmer" used for this purpose has the advantage of being able to maintain a constant temperature of 44 degrees-45 degrees C on the skin surface for several hours, while permitting unrestricted freedom of movement. The duration of treatment depends on the type of lesion, location, depth, and size. Generally, local application for 1-2 h per day, or in sleep time, for 5-6 weeks seems to be sufficient.
Sporotrichosis
Leishmaniasis
Dermatomycosis
Mycobacterium marinum
Botryomycosis
Cat-scratch disease
Otomycosis
Leprosy